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SUMMARY. A quantitative structure activity relationship (QSAR) analysis was performed on two series of
benzoxazole-phenoxyalkyl-phenoxybutyric acids with potent PPARα activation activity using diverse de-
scriptors. The 31 compounds were divided into a training set and a test set based on Euclidean distance.
The model was derived through multiple linear stepwise regression method and the predictive ability of
the best model was validated by leave-one-out cross-validation and external validation on the test set. The
best generated QSAR model explained good fits to the experimental data with approximate 80 % of the
variance in the biological activity. Also, the important cross-validated squared correlation coefficient (r2 =
0.697) and the accuracy of 90 % correct predictions for the test set further confirmed that the model ex-
hibited reliable predictive power ability. The generated QSAR model revealed that PPARα activation ac-
tivity of benzoxazole-phenoxyalkyl-phenoxybutyric acids was influenced by the presence of chiral centers
and hydrogen bonding donor groups and the number of positive charges and positive polar charges in the
molecule, which might help in developing new PPARα agonists with better activity.
